← Eichor
Condition: Oesophageal Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Oesophageal Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma
Phase 2 · 8 location(s) · Ming-Yu Lien · NCT07039162AI-Assisted Non-Contrast CT for Multi-Cancer Screening
NA · 1 location(s) · Guo ShiWei · NCT06632886Distance-Based Exercise to Preserve Function and Prevent Disability
NA · 18 location(s) · Alliance for Clinical Trials in Oncology · NCT07059884A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07224750Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous C
Phase 2 · 1 location(s) · Tongji Hospital · NCT07699185Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06452602a Single-arm, Single-center, Open Clinical Study
Phase N/A · 1 location(s) · Beijing Geekgene Technology Co., LTD · NCT06431100A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (
Phase 3 · 88 location(s) · Daiichi Sankyo · NCT06644781A Multicenter Cancer Biospecimen Collection Study
Phase N/A · 1 location(s) · Cofactor Genomics, Inc. · NCT04510129A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
Phase 1 · 37 location(s) · Aurigene Discovery Technologies Limited · NCT05865002Folfox+Irinotecan+Chemort In Esophageal Cancer
Phase 2 · 3 location(s) · Massachusetts General Hospital · NCT04656041The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy
NA · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07187154Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant
Phase N/A · 1 location(s) · Tongji Hospital · NCT07088354CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
Phase 3 · 1 location(s) · Fudan University · NCT06964568Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Pos
Phase 2 · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06885814At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860DESTINY-PANTUMOUR04
Phase N/A · 18 location(s) · AstraZeneca · NCT07124000cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Phase N/A · 17 location(s) · Adela, Inc · NCT05366881Adebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally Advanced Esophageal Squamous Cell Ca
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07638436A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Phase 1 · 2 location(s) · Immunome, Inc. · NCT07578571EsophaCap for the Detection of Early Esophageal Carcinoma
Phase N/A · 2 location(s) · Johns Hopkins University · NCT04214119RAMIE Versus MIE for Resectable Esophageal Cancer, a Randomized Controlled Trial (ROBOT-2 Trial).
NA · 1 location(s) · University Medical Center Mainz · NCT04306458Exploratory Clinical Study of Camrelizumab Combined With Concurrent Chemoradiotherapy as an Organ-preserving Strategy fo
Phase 2 · 1 location(s) · The First Affiliated Hospital of Henan University of Science · NCT07622797A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC
Phase 2 · 1 location(s) · The First Affiliated Hospital of Zhengzhou University · NCT05182944Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Act
Phase 2/Phase 3 · 3 location(s) · KU Leuven · NCT06782412Molecular Assessment for Gastro-Esophageal Cancer
NA · 1 location(s) · KU Leuven · NCT06346054Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal
Phase N/A · 1 location(s) · Anhui Provincial Hospital · NCT05833594A Study of SH009 Injection in Patients With Advanced Solid Tumors.
Phase 1 · 1 location(s) · Nanjing Sanhome Pharmaceutical, Co., Ltd. · NCT07390838Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck
Phase 1 · 48 location(s) · AbbVie · NCT05005403Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CR
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT06509568
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.